164 related articles for article (PubMed ID: 11562401)
1. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function.
Margetts PJ; Kolb M; Galt T; Hoff CM; Shockley TR; Gauldie J
J Am Soc Nephrol; 2001 Oct; 12(10):2029-2039. PubMed ID: 11562401
[TBL] [Abstract][Full Text] [Related]
2. A chronic inflammatory infusion model of peritoneal dialysis in rats.
Margetts PJ; Kolb M; Yu L; Hoff CM; Gauldie J
Perit Dial Int; 2001; 21 Suppl 3():S368-72. PubMed ID: 11887858
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
5. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
[TBL] [Abstract][Full Text] [Related]
6. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.
Margetts PJ; Gyorffy S; Kolb M; Yu L; Hoff CM; Holmes CJ; Gauldie J
J Am Soc Nephrol; 2002 Mar; 13(3):721-728. PubMed ID: 11856777
[TBL] [Abstract][Full Text] [Related]
8. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.
Margetts PJ; Kolb M; Yu L; Hoff CM; Holmes CJ; Anthony DC; Gauldie J
Am J Pathol; 2002 Jun; 160(6):2285-94. PubMed ID: 12057931
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of enalapril on chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Ke CY; Lin NT; Hsu BG
Chin J Physiol; 2011 Aug; 54(4):225-34. PubMed ID: 22129820
[TBL] [Abstract][Full Text] [Related]
13. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1α, VEGF and TGF-β1.
Li J; Guo ZY; Gao XH; Bian Q; Jia M; Lai XL; Wang TY; Bian XL; Wang HY
PLoS One; 2015; 10(2):e0118481. PubMed ID: 25723475
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.
Szeto CC; Wong TY; Lai KB; Chow KM; Li PK
Perit Dial Int; 2002; 22(2):265-7. PubMed ID: 11990414
[No Abstract] [Full Text] [Related]
16. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta: importance in long-term peritoneal membrane changes.
Margetts PJ; Oh KH; Kolb M
Perit Dial Int; 2005 Feb; 25 Suppl 3():S15-7. PubMed ID: 16048248
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
